Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 8, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | A | B | $20.84B | $2.47B | $885.58M | $512.73M | $4.26 | 11.42% | 12.00% | 71.77% | 41.16% | |
| TPR | TAPESTRY INC | A | B | $20.22B | $7.21B | $598.20M | $271.40M | $1.36 | 8.14% | 8.58% | -61.36% | N/A | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | B | $8.15B | $4.16B | $182.64M | -$368.48M | -$5.99 | 4.14% | 12.77% | N/A | N/A | |
| MOG.A | MOOG INC | A | B | $6.33B | $3.73B | $436.71M | $211.62M | $6.66 | 4.77% | 4.88% | 4.39% | 11.70% | |
| SGHC | SUPER GROUP (SGHC) LTD | A | C | $5.94B | $2.50B | N/A | $250.52M | $0.50 | 37.25% | N/A | 2,420.00% | N/A | |
| GTES | GATES INDUSTRIAL CORP PLC | A | B | $5.56B | $3.42B | $672.10M | $236.70M | $0.92 | -0.75% | 4.63% | 9.52% | 29.77% | |
| CALX | CALIX INC | A | A | $4.27B | $933.69M | $10.21M | -$7.25M | -$0.10 | 4.89% | 13.70% | N/A | N/A | |
| DLO | DLOCAL LTD | A | B | $3.99B | $863.48M | $243.80M | $145.90M | $0.51 | 22.02% | N/A | 10.87% | N/A | 2025-11-18 |
| RSI | RUSH STREET INTERACTIVE INC | A | A | $3.80B | $1.06B | -$33.04M | $30.09M | $0.33 | 23.15% | 42.91% | N/A | 75.18% | |
| TPC | TUTOR PERINI CORP | A | A | $3.55B | $5.10B | $108.27M | -$27.83M | -$0.54 | 19.22% | -0.17% | N/A | N/A | |
| MIRM | MIRUM PHARMACEUTICALS INC | A | A | $3.40B | $429.16M | -$17.20M | -$58.56M | -$1.21 | 62.33% | N/A | N/A | N/A | 2025-11-12 |
| FOLD | AMICUS THERAPEUTICS INC | A | B | $2.74B | $571.16M | $33.06M | -$38.10M | -$0.12 | 25.35% | 20.27% | N/A | N/A | |
| EXTR | EXTREME NETWORKS INC | A | A | $2.34B | $1.18B | $65.83M | $8.65M | $0.07 | 14.31% | 4.93% | N/A | N/A | |
| SPNT | SIRIUSPOINT LTD | A | A | $2.26B | $2.84B | $339.10M | $182.30M | $1.66 | 7.87% | 30.11% | 0.00% | 32.93% | |
| IHS | IHS HOLDING LTD | A | B | $2.15B | $1.73B | N/A | $110.87M | $0.34 | -5.40% | N/A | N/A | N/A | 2025-11-18 |
| ARDT | ARDENT HEALTH INC | A | C | $2.07B | $6.20B | $541.00M | $254.86M | $1.86 | 10.03% | N/A | 169.57% | N/A | |
| FIVN | FIVE9 INC | A | A | $1.66B | $1.11B | $98.42M | $8.83M | $0.13 | 14.21% | 24.42% | N/A | N/A | 2025-11-10 |
| BLBD | BLUE BIRD CORP | A | B | $1.60B | $1.42B | $175.74M | $115.89M | $3.63 | 9.31% | 8.58% | 17.48% | 51.82% | 2025-12-10 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | A | $1.48B | $557.51M | $63.44M | -$35.71M | -$0.18 | 45.85% | 62.51% | N/A | N/A | |
| CRTO | CRITEO SA | A | C | $1.18B | $1.96B | $219.28M | $168.06M | $3.12 | 0.53% | -1.06% | 71.43% | 23.41% | |
| NRDS | NERDWALLET INC | A | B | $892.66M | $734.90M | $51.20M | $29.50M | $0.39 | 24.20% | N/A | N/A | N/A | |
| UDMY | UDEMY INC | A | B | $759.70M | $795.80M | $28.86M | -$3.73M | -$0.03 | 2.53% | N/A | N/A | N/A | |
| TBPH | THERAVANCE BIOPHARMA INC | A | A | $748.87M | $77.21M | $48.42M | $13.03M | $0.25 | 24.49% | 0.11% | N/A | N/A | 2025-11-10 |
| LYTS | LSI INDUSTRIES INC | A | C | $630.08M | $573.38M | $48.74M | $24.38M | $0.82 | 22.09% | 13.41% | -4.65% | 17.25% | |
| BWMN | BOWMAN CONSULTING GROUP LTD | A | A | $593.85M | $444.59M | $24.06M | $2.57M | $0.16 | 21.78% | N/A | N/A | N/A | |
| AKBA | AKEBIA THERAPEUTICS INC | A | A | $527.90M | $184.91M | $10.87M | -$45.31M | -$0.22 | -1.24% | -12.02% | N/A | N/A | |
| KMDA | KAMADA LTD | A | C | $380.68M | $169.52M | $34.21M | $19.01M | $0.33 | 9.67% | 5.21% | 17.86% | -7.60% | 2025-11-12 |
| EGHT | 8X8 INC | A | B | $268.65M | $718.28M | $41.70M | -$21.24M | -$0.16 | -0.73% | 8.79% | N/A | N/A | |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | C | $242.14M | $460.82M | $43.34M | $14.11M | $0.77 | 4.33% | 4.86% | -3.75% | 6.20% | |
| INFU | INFUSYSTEM HOLDINGS INC | A | C | $209.26M | $141.05M | $24.16M | $5.52M | $0.26 | 6.23% | 8.37% | 333.33% | -7.31% | 2025-11-11 |
| CXDO | CREXENDO INC | A | B | $207.43M | $66.35M | $7.94M | $4.36M | $0.15 | 12.91% | 33.25% | 150.00% | 16.47% | |
| ELMD | ELECTROMED INC | A | C | $203.22M | $64.00M | $11.32M | $7.54M | $0.89 | 16.97% | 14.53% | 48.33% | 12.22% | 2025-11-11 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.